Filing metadata

Accession number
0000905148-24-001481
Form type
Form 3
Filer
Acrivon Therapeutics, Inc.
CIK
CIK 1781174
Filed
May 16, 2024
Reporting period
May 13, 2024
Description
Initial ownership

Explore SEC Filings Hub